Log inSign up
AAOIFI No. 21 screening

Is APLM halal?

Apollomics Inc.

Halal

Apollomics Inc. passed every check under AAOIFI Shariah standard No. 21: no prohibited business activity, and all three financial ratios are within limits.

Checked: 14 October 2026

Exchange

NASDAQ

Price

21.1

Day

+0.00%

Market cap

$61.7M

Industry

Biotechnology

Sector

Healthcare

What the company does

Apollomics (China/US) is an oncology biotech: vebreltinib (lung cancer, approved in China) and other pipeline drugs. Revenue is tiny; its money comes from partnerships and drug sales.

What was checked

The AAOIFI standard has four steps: business activity first, then three financial ratios. Fail one and the stock is not halal.

  • Business activity

    No prohibited activity

  • Interest-bearing debt / market cap

    limit 30%

    Interest-bearing debt $643K ÷ 36-month average market cap $30.04M = 2.1%

    2.1%

    Pass

  • Cash & investments / market cap

    limit 30%

    Cash + interest-bearing securities $3.28M ÷ 36-month average market cap $30.04M = 10.9%

    10.9%

    Pass

  • Non-compliant income / total revenue

    limit 5%

    Interest income $152K ÷ annual revenue $8.50M (2025) = 1.8%

    1.8%

    Pass

Figures from the company's filings (2025-12-31), USD. Market cap is a 36-month average (the S&P Shariah index approach), so a one-day price move does not flip the verdict. Today's market cap: $61.71M.

For information (AAOIFI 3/1 note): cash + receivables are 85.9% of total assets (2025-12-31). AAOIFI recommends tangible assets of at least one third — this figure does not affect the verdict, and other major screeners do not apply it either.

In the lists

In the S&P 500
Not in the S&P 500
Among halal stocks
0.00% · #1257 of 1454

Halal stocks in the same industry

The largest halal stocks in Biotechnology — for comparison.

Related articles

Halal is the first question. The second: when to enter?

Our scanner watches 1454 halal stocks around the clock and fires a signal with entry, TP and SL when a technical setup completes. The full signal history — with outcomes — is public.

This is neither investment advice nor a fatwa. Screening is based on public financial statements and AAOIFI standard No. 21; data may lag. For a personal decision consult your own scholar.